|
|
Volumn 18, Issue 3, 2010, Pages 269-
|
|
Practical limitations of prescribing olanzapine depot (Relprevv)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUPENTIXOL;
LITHIUM;
MOOD STABILIZER;
OLANZAPINE;
RELPREVV;
UNCLASSIFIED DRUG;
COMMUNITY MENTAL HEALTH;
HUMAN;
INVOLUNTARY COMMITMENT;
LETTER;
NARCISSISM;
PATIENT COMPLIANCE;
PATIENT MONITORING;
PATIENT SAFETY;
PRESCRIPTION;
SCHIZOAFFECTIVE PSYCHOSIS;
SUBSTANCE ABUSE;
TREATMENT FAILURE;
ANTIPSYCHOTIC AGENTS;
AUSTRALIA;
BENZODIAZEPINES;
COMMITMENT OF MENTALLY ILL;
DELAYED-ACTION PREPARATIONS;
HEALTH SERVICES MISUSE;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
INSERVICE TRAINING;
MONITORING, PHYSIOLOGIC;
NEW ZEALAND;
PATIENT CARE TEAM;
PATIENT COMPLIANCE;
PSYCHIATRIC DEPARTMENT, HOSPITAL;
PSYCHIATRIC NURSING;
PSYCHOTIC DISORDERS;
RESUSCITATION;
|
|
EID: 77952795472
PISSN: 10398562
EISSN: 14401665
Source Type: Journal
DOI: 10.3109/10398561003733912 Document Type: Letter |
|
Times cited : (7)
|
|
References (0)
|
